Skip to main content
. 2018 Aug 10;57(24):3521–3528. doi: 10.2169/internalmedicine.0990-18

Table 1.

Dose Attenuation by Patients’ Age.

Age CY DOX VCR PSL R
≤59 100% 100% 100% 100 mg/body 100%
60-69 100% 100% 100% 50 mg/m2 100%
70-79 75% 75% 75% 40 mg/m2 100%
≥80 50% 50% 50% 30 mg/m2 100%

CY: cyclophosphamide, DOX: doxorubicin, PSL: prednisone, R: rituximab, VCR: vincristine